A pharmacy is a facility whose primary function is to store, prepare and legally dispense prescription drugs under the professional supervision of a licensed pharmacist. It meets any licensing or certification standards set forth by the jurisdiction where it is located. Provider's Other Legacy Identifiers: Identifier Identifier Type Identifier State Identifier Issuer 4218245 Other SC NABPA. A facility used by pharmacists for the compounding and dispensing of medicinal preparations and other associated professional and administrative services. A pharmacy is a facility whose primary function is to store, prepare and legally dispense prescription drugs under the professional supervision of a licensed pharmacist.
It meets any licensing or certification standards set forth by the jurisdiction where it is located. Mail Order Pharmacy A pharmacy which uses common carriers to deliver the medications to patient or their caregivers. Mail order pharmacies counsel patients and caregivers (sometimes independent of the dispensing process) through telephone or email contact and provide other professional services associated with pharmaceutical care appropriate to the setting. Mail order pharmacies are licensed as a Mail Order Pharmacy in the state where they are located and may also be licensed or registered as nonresident pharmacies in other states. Non-Pharmacy Dispensing Site A site other than a pharmacy that dispenses medicinal preparations under the supervision of a physician to patients for self-administration. physician offices, ER, Urgent Care Centers, Rural Health Facilities, etc.) Specialty Pharmacy A pharmacy that dispenses generally low volume and high cost medicinal preparations to patients who are undergoing intensive therapies for illnesses that are generally chronic, complex and potentially life threatening. Often these therapies require specialized delivery and administration. : The National Provider Identifier (NPI) is a unique identification number for covered health care providers. The NPI is a 10-position, intelligence-free numeric identifier (10-digit number).
This means that the numbers do not carry other information about healthcare providers, such as the state in which they live or their medical specialty. The NPI must be used in lieu of legacy provider identifiers in the HIPAA standards transactions. Covered health care providers and all health plans and health care clearinghouses must use the NPIs in the administrative and financial transactions adopted under HIPAA (Health Insurance Portability and Accountability Act). Jay Watts, R.Ph., FACA, FACVP University of South Carolina College of Pharmacy "Our promise is a quality-driven service, and our focus is to ensure affordable access to the medications you need at a price you will love." Refill. Where You Are Always Number 1 |Donde siempre eres el número uno. Couldn't ask for a better pharmacy in the Aiken area! Thank you Jay (and family) for all you do for our community! Excellent service with outstanding staff to help however they can with every customer. Family is at the core of who they are and how they operate. (a)(1) This section shall be known and may be cited as Leni's Law. (2) For the purposes of this section, the following terms shall have the following meanings: a. A (nonpsychoactive) cannabinoid found in the plant Cannabis sativa L. or any other preparation thereof that is free from plant material, and has a THC level (delta-9-tetrahydrocannibinol) of no more than three percent relative to CBD according to the rules adopted by the Alabama Department of Forensic Sciences. Also known as (synonyms): 2-[(1R,6R)-3-Methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol; trans-(-)-2-p-mentha-1,8-dien-3-yl-5-pentylresorcinol; (-)-Cannabidiol; (-)-trans-Cannabidiol; Cannabidiol (7CI); D1(2)-tran-Cannabidiol and that is tested by an independent third-party laboratory. A chronic or debilitating disease or medical condition including one that produces seizures for which a person is under treatment. (3) In addition to the affirmative defense provided in Section 13A-12-214.2 , in a prosecution for the unlawful possession of marijuana in the second degree under Section 13A-12-214 , it is an affirmative and complete defense that the defendant used or possessed CBD if the defendant satisfies either of the following: a. He or she is the parent or legal guardian of a minor who has a debilitating medical condition, and the CBD is being used by the minor. (4) An agency of this state or a political subdivision thereof, including any law enforcement agency, may not initiate proceedings to remove a child from the home of a parent or guardian, nor initiate any child protection action or proceedings, based solely upon the parent's or child's possession or use of CBD as allowed by this section. (5) Nothing in this section shall be construed to require the various individual or group insurance organizations providing protection, indemnity, or insurance against hospital, medical, or surgical expenses, or health maintenance organizations to provide payment or reimbursement for prescriptions of CBD. (6) Nothing in this section shall be construed to allow or accommodate the prescription, testing, medical use, or possession of any other form of Cannabis other than that defined in this section. (b) The Legislature finds and declares the following: (1) This section is intended to authorize only the limited use of nonpsychoactive CBD as defined in this section only for specified debilitating conditions that produce seizures, and is not intended as a generalized authorization of medical marijuana. (2) It is the intent of the Legislature to maintain existing criminal prohibitions of marijuana, except as expressly provided in existing law or as expressly provided in this section. Alabama Legislature approves Leni's Law to decriminalize cannabis derivative. Families who helped push through the passage of Leni's Law were at the Alabama State House on Wednesday. From left are Meggan Jackson of Lester and her son, Caden; Kari Forsyth of Athens and her daughter, Chesney; and Brittany Townsend of Hueytown and her daughter, Kenna.
(Mike Cason/[email protected]) A bill to allow people with seizure disorders or other debilitating medical conditions to use a product that comes from the same plant as marijuana was passed by the Alabama Legislature today. The state Senate approved the bill, called Leni's Law, by a 29-3 vote. The House later voted 95-4 to concur with the bill and send it to Gov. The bill would decriminalize cannabidiol, derived from cannabis, for those with certain medical conditions. The bill is named after Leni Young, an Alabama child whose family moved to Oregon so she could use cannabidiol to treat severe seizures. The product is legal there and in some other states, but not in Alabama. Young's father told lawmakers earlier this year that Leni's condition had improved markedly since the move. The bill would expand on Carly's Law, passed two years ago, that authorized a UAB study on using cannabidiol to treat seizure disorders.
Preliminary results from the UAB study have been promising, Sen. Paul Sanford, R-Huntsville, the Senate sponsor of Leni's Law, said today. UAB reported in March that 50 percent of 51 people in the study saw sustained improvement in seizure control. Parents who believe their children could benefit have been leading advocates for both bills, making repeated trips to the State House. Some were in the House gallery when the bill passed tonight.